Social Mixer 2024 Singapore
marketing interactive Content360 Singapore 2024 Content360 Singapore 2024
Pharma company Boehringer Ingelheim shifts account from Zenith to OMD

Pharma company Boehringer Ingelheim shifts account from Zenith to OMD

share on

Pharmaceutical company Boehringer Ingelheim has named OMD to manage global media duties for its animal health category. Marketing understands that the assignment covers Asia Pacific, EMEA and the US and will involve cross media, cross channel planning and buying.The billings are estimated to be from US$90 million to US$100 million and the remit includes tick prevention spray FRONTLINE and beef-flavoured chew NexGuard, Marketing understands.In a statement to Marketing, Zenith’s spokesperson said: “Boehringer Ingelheim is a global client of Zenith. In Singapore, it hasn’t been an active business.”Boehringer Ingelheim was established in 1885 and aims to improve the health of humans and animals. It focuses on diseases for which no satisfactory treatment option exists to date, and develops innovative therapies that can extend patients’ lives. Last year, it achieved net sales of about 17.5 billion euros. It also had an R&D expenditure of about 3.2 billion euros.

share on

Follow us on our Telegram channel for the latest updates in the marketing and advertising scene.
Follow

Free newsletter

Get the daily lowdown on Asia's top marketing stories.

We break down the big and messy topics of the day so you're updated on the most important developments in Asia's marketing development – for free.

subscribe now open in new window